Key Corporate Highlights
- Senthil Infotek Limited is undergoing an open offer by promoters Kolli Murali Krishna and Gogineni Srinivas to acquire up to 13.13 lakh equity shares (26% stake) at ₹8 per share. The offer will remain open from June 18 to July 2, 2026, with Synfinx Capital acting as the manager to the offer.
- Cohance Lifesciences Ltd received shareholder approval for all five resolutions through postal ballot. Key approvals include:
- Appointment of Umang Vohra as Chairman & Group CEO.
- Approval of remuneration exceeding statutory limits.
- Launch of Employee Stock Option Plan (ESOP) 2026.
- Extension of ESOP benefits to unlisted subsidiaries.
- Grant of stock options up to 1% of issued share capital annually.
- Smartworks strengthened its international presence by adding 15,000+ sq. ft. at Manulife Tower, Singapore, taking its total footprint in the city-state to over 50,000 sq. ft.
- Expansion targets multinational corporations, GCCs, and Fortune 500 firms.
- The company reported FY26 revenue of ₹1,796 crore, reflecting 31% YoY growth.
- Achieved its first full year of PAT profitability, marking a key operational milestone.
- Embassy Developments Ltd appointed Leighton Asia as the construction partner for its flagship luxury residential project Embassy Citadel in Mumbai's Worli district.
- Construction contract value exceeds ₹850 crore.
- Leighton Asia will execute the entire civil and structural works package.
- The project spans approximately 1.6 million sq. ft.
- Includes 316 ultra-luxury residences, ranging from 3-BHK to exclusive triplex mansion homes.
- Features around 1 lakh sq. ft. of lifestyle amenities and a premium Sky Lounge.
- The tower is expected to rise nearly 300 metres, making it one of Mumbai's prominent luxury developments.
